Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.180
-0.150 (-11.28%)
Nov 13, 2026, 4:00 PM EST - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $84.72 million as of November 13, 2026. Its market cap has decreased by 67.91% in one year.
Market Cap
84.72M
Enterprise Value
-32.70M
1-Year Change
-67.91%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $84.72M, a decrease of -93.70%. That is a compound annual growth rate of -21.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 84.72M | -75.80% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coherus Oncology | 81.21M |
| Neumora Therapeutics | 80.59M |
| Tenaya Therapeutics | 79.59M |
| Atara Biotherapeutics | 77.29M |
| Nutriband | 74.15M |
| Coya Therapeutics | 73.42M |
| Rani Therapeutics Holdings | 73.36M |
| Milestone Pharmaceuticals | 73.27M |